Company: IIPR
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001104659-25-041241
Chunk: 21

Company: INNOVATIVE INDUSTRIAL PROPERTIES INC
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 21
---
 In addition, our Board has adopted Corporate Governance Guidelines to assist the Board in the exercise of its responsibilities and to serve the interests of the Company and its stockholders. The Code of Business Conduct and Ethics and Corporate Governance Guidelines is available in the “Investors” section of our website ( www.innovativeindustrialproperties.com ). Insider Trading Policies and Procedures We have adopted an insider trading policyapplicable to our directors, officers and employees and have implemented processes for the Company that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations, as well as NYSE listing standards. A copy of our insider trading policy was filed as an exhibit to our Annual Report on Form 10-K for the year ended December 31, 2024. Director Stock Ownership Guidelines We have adopted stock ownership guidelines for our non-employee directors. Under these guidelines, each non-employee director is required to hold stock valued at no less than five times the amount of the annual cash retainer paid to such director for service as a member of the Board, without reference to committee or chair service. 12

TABLE OF CONTENTS

Committee Membership (1) The Board has established standing audit, compensation, and nominating and corporate governance committees. Membership on each of these committees, as of April 29, 2025, is shown in the following chart:

| ​ | ​                             | ​ | ​ | Audit Committee | ​ | ​ | CompensationCommittee | ​ | ​ | Nominating and CorporateGovernance Committee | ​ |
| ​ | Gary Kreitzer                 | ​ | ​ |               X | ​ | ​ |                 Chair | ​ | ​ |                                            X | ​ |
| ​ | Mary Curran(2)                | ​ | ​ |               X | ​ | ​ |                     ​ | ​ | ​ |                                            X | ​ |
| ​ | Scott Shoemaker, M.D.         | ​ | ​ |               ​ | ​ | ​ |                     X | ​ | ​ |                                        Chair | ​ |
| ​ | David Stecher(2)              | ​ | ​ |           Chair | ​ | ​ |                     X | ​ | ​ |                                            ​ | ​ |
| ​ | Number of Meetings in 2024(3) | ​ | ​ |               4 | ​ | ​ |                     4 | ​ | ​ |                                            2 | ​ |

(1) The Board periodically reviews committee membership and may rotate membership during the year. Accordingly, the membership described in the table may change